NICU, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, 20122, Italy
NCT Number: NCT04293601
Nasal Continuous Positive Airway Pressure (NCPAP) is a respiratory support for neonates with Respiratory Distress Syndrome (RDS) and represents the gold standard for RDS treatment in many Neonatal Intensive Care Units (NICU). Respiratory supports providing Synchronized Nasal Intermittent Positive Pressure Ventilation may further enhance the success of non-invasive respiratory support.
The most significant risk factor associated to NCPAP management is nasal trauma. Nasal injuries represent a source of pain and discomfort for infants. In some cases, they could become a site of infection and cause functional, cosmetic, long term outcomes as erythema or necrosis of the columella nasi.
The aim of this study is to evaluate the effectiveness of nursing interventions to reduce the incidence of pressure injuries during NCPAP support in infants admitted to NICU.
It is hypothesized that implementation of some preventive interventions could improve nursing care quality and reduce nasal pressure injuries.
Looking for future studies?
Notify MeUp to 6 month
All sexes
Interventional
Not applicable
Milan, 20122, Italy
Previous studies highlighted that nasal trauma, due to NCPAP support, is caused by the following risk factors:
However, previous studies results are mixed regarding factors affecting nasal injuries in neonates supported with NCPAP.
Interventions indicated as protective are:
Hence, aim of this study is:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The infants enrolled will receive different intervention according to a defined risk factor level:
"Low":
Interventions:
"Medium":
Interventions:
"High":
Interventions:
Other names: prospective group
Other names: retrospective group
Time frame: Through study completion, an average of 27 months
Evaluation of the number of pressure nasal injuries
Time frame: Determined at the time of birth (GA) and at the time of nasal injury onset (PMA), an average of 2 months
Gestational Age (weeks) and postmenstrual age (weeks) will be collected from electronical medical records
Time frame: Measured at the time of birth and at the time of presentation of nasal injury, an average of 2 months
Newborns' weight (grams) will be collected from electronical medical records
Time frame: From the beginning of NCPAP treatment until the end of NCPAP treatment, an average of 2 months
Duration NCPAP treatment (days) will be collected from electronical medical records
Time frame: From admission in NICU until NICU discharge or transfer in an other ward, an average of 2 months
Duration of stay in NICU (days) will be collected from electronical medical records
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Other
Pressure Injuries' Prevention in Newborn Infants Admitted to NICU Receiving Noninvasive Respiratory Support With Nasal Continuous Positive Airway Pressure (NCPAP)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03109444
Hip Dislocation, Hip Dysplasia
Fresno, California, United States
View Trial DetailsNCT07686627
Agnosia, Heel Prick
Kocaeli, İzmit, Turkey (Türkiye)
View Trial DetailsNCT03117907
Infection, Infections
Amiens, Picardie, France
View Trial DetailsNCT06706804
Education, Newborn
Kahramanmaraş, Turkey (Türkiye)
View Trial Details